Business Description
Ekso Bionics Holdings Inc
NAICS : 339112
SIC : 3841
ISIN : US2826443010
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.31 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | -0.69 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -11.36 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | 23.2 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 10.3 | |||||
3-Year Book Growth Rate | 16.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 20.04 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.87 | |||||
9-Day RSI | 41.54 | |||||
14-Day RSI | 39.43 | |||||
6-1 Month Momentum % | -30.07 | |||||
12-1 Month Momentum % | -54.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.81 | |||||
Quick Ratio | 2.14 | |||||
Cash Ratio | 1.1 | |||||
Days Inventory | 219.86 | |||||
Days Sales Outstanding | 127.05 | |||||
Days Payable | 87.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.2 | |||||
Shareholder Yield % | -63.59 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.84 | |||||
Operating Margin % | -66.05 | |||||
Net Margin % | -62.95 | |||||
FCF Margin % | -56.87 | |||||
ROE % | -80.84 | |||||
ROA % | -38.32 | |||||
ROIC % | -70.31 | |||||
ROC (Joel Greenblatt) % | -120.3 | |||||
ROCE % | -50.83 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.58 | |||||
PB Ratio | 0.88 | |||||
Price-to-Tangible-Book | 1.33 | |||||
EV-to-EBIT | -1.05 | |||||
EV-to-EBITDA | -1.23 | |||||
EV-to-Revenue | 0.65 | |||||
EV-to-Forward-Revenue | 0.49 | |||||
EV-to-FCF | -1.1 | |||||
Price-to-Median-PS-Value | 0.14 | |||||
Price-to-Net-Current-Asset-Value | 1.88 | |||||
Earnings Yield (Greenblatt) % | -95.61 | |||||
FCF Yield % | -75.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ekso Bionics Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 17.682 | ||
EPS (TTM) ($) | -0.65 | ||
Beta | 0.39 | ||
Volatility % | 77.68 | ||
14-Day RSI | 39.43 | ||
14-Day ATR ($) | 0.030199 | ||
20-Day SMA ($) | 0.678147 | ||
12-1 Month Momentum % | -54.4 | ||
52-Week Range ($) | 0.6015 - 3.1 | ||
Shares Outstanding (Mil) | 22 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ekso Bionics Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ekso Bionics Holdings Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Ekso Bionics Holdings Inc Frequently Asked Questions
What is Ekso Bionics Holdings Inc(LTS:0IFR)'s stock price today?
When is next earnings date of Ekso Bionics Holdings Inc(LTS:0IFR)?
Does Ekso Bionics Holdings Inc(LTS:0IFR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |